|
|
40
|
5591A
|
CERUMOL EAR DR (THR/SBI) PROPYLENE GLYCOL | TU
|
11ML
|
A
|
4.35
|
|10%
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
5591B
|
WAXONIL 2%|15% EAR DR (SPC) PARADICHLOROBENZENE|TURPENTINE O
|
10ML BOTT
|
A
|
6.4424
|
2%|15%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
5591B
|
WAXONIL 2%|15% EAR DR (SPC) PARADICHLOROBENZENE|TURPENTINE O
|
10ML
|
A
|
6.80
|
2%|15%
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
5591C
|
SOLYEAR 8.4% EAR DR (JLP) PARADICHLOROBENZENE
|
10ML
|
A
|
5.44
|
8.4%
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
5621D
|
DERMOVATE 0.05% CR (GSK/COL) CLOBETASOL
|
30G
|
C
|
23.92
|
0.05%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
5621D
|
DERMOVATE 0.05% CR (GSK) CLOBETASOL (C)
|
30G
|
C
|
26.3134
|
0.05%
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
5621D
|
DERMOVATE 0.05% CR (GSK) CLOBETASOL
|
30G
|
C
|
28.95
|
0.05%
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
5621E
|
DERMOVATE 0.05% OINT (GSK/COL) CLOBETASOL
|
30G
|
C
|
23.92
|
0.05%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
5621E
|
DERMOVATE 0.05% OINT (GSK) CLOBETASOL (C)
|
30G
|
C
|
26.3134
|
0.05%
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
5621E
|
DERMOVATE 0.05% OINT (GSK) CLOBETASOL
|
30G
|
C
|
28.95
|
0.05%
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
5621P
|
CLOBETASOL 0.05% LOT (CHC/ATB)
|
60ML
|
C
|
6.96
|
0.05%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
40
|
56222
|
CLOBETASOL 0.05% SHAMP (WOC/AHI)
|
50ML
|
C
|
70.68
|
0.05%
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
56223
|
CLOBETASONE 0.05% SHAMP (GLP) CLOB (C)
|
100ML
|
C
|
48.93
|
0.05%
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
41
|
5641AK
|
ROCEPHIN 1G IV INJ (ROC) CEFTRIAXONE (C)
|
1G VIAL
|
C
|
12.2325
|
1G IV
|
28
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
5641AK
|
ROCEPHIN 1G IV INJ (ROC) CEFTRIAXONE
|
1G VIAL
|
C
|
12.23
|
1G IV
|
28
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
5641BS
|
C ZID 1G INJ (EMC/COL) CEFTAZIDIME
|
1G VIAL
|
B
|
4.08
|
1G
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
5641BS
|
C ZID 1G INJ (EMC) CEFTAZIDIME (B)
|
1G VIAL
|
B
|
6.7958
|
1G
|
28
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
5641BS
|
C ZID 1G INJ (EMC) CEFTAZIDIME
|
1G VIAL
|
B
|
8.70
|
1G
|
28
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
5641BT
|
C TRI 1G IV/IM INJ (EMC/COL) CEFTRIAXONE
|
1G VIAL
|
C
|
2.99
|
1G IV/IM
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
5641BT
|
C TRI 1G IV/IM INJ (EMC) CEFTRIAXONE (C)
|
1G VIAL
|
C
|
4.893
|
1G IV/IM
|
28
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
